ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

Scientific Community Rallies To Support DeVita; Immediate Suspension Of Straus’ Grant Considered

June 12, 1981

ODAC Discussion: NCI’s Richard Simon Cautions About Rules Of Thumb

January 30, 2009

CDC Offers Funds For 5-A-Day Program; CDC PA Available

May 14, 1999

Clinical Trials Approved By NCI CTEP Last Month

April 29, 2011

Childhood Cancer Foundation Names New President

September 20, 2002

FASEB Urges Congress To Fund Stem Cell Research.

July 27, 2001